Literature DB >> 149884

Ipratropium bromide (Sch 1000) monohydrate aerosol: bronchodilator effect of three dose levels in asthmatics.

R E Ruffin, M T Newhouse.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 149884     DOI: 10.1007/bf02730688

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


× No keyword cloud information.
  7 in total

1.  Sch 1000: a new anticholinergic bronchodilator.

Authors:  M J Gross
Journal:  Am Rev Respir Dis       Date:  1975-12

2.  Aerosol penetrance: a sensitive index of peripheral airways obstruction.

Authors:  M B Dolovich; J Sanchis; C Rossman; M T Newhouse
Journal:  J Appl Physiol       Date:  1976-03       Impact factor: 3.531

3.  Aerosol therapy with Sch 1000. Short-term mucociliary clearance in normal and bronchitic subjects and toxicology in normal subjects.

Authors:  R E Ruffin; R K Wolff; M B Dolovich; C M Rossman; J D Fitzgerald; M T Newhouse
Journal:  Chest       Date:  1978-04       Impact factor: 9.410

4.  A reduction in maximum mid-expiratory flow rate. A spirographic manifestation of small airway disease.

Authors:  E R McFadden; D A Linden
Journal:  Am J Med       Date:  1972-06       Impact factor: 4.965

5.  beta-adrenergic agonist resistance in normal human airways.

Authors:  S T Holgate; C J Baldwin; A E Tattersfield
Journal:  Lancet       Date:  1977-08-20       Impact factor: 79.321

6.  Comparative trial of a new anticholinergic bronchodilator, Sch 1000, and salbutamol in chronic bronchitis.

Authors:  H Poppius; Y Salorinne
Journal:  Br Med J       Date:  1973-10-20

7.  A comparison of the bronchodilator activity of Sch 1000 and salbutamol.

Authors:  R E Ruffin; J D Fitzgerald; A S Rebuck
Journal:  J Allergy Clin Immunol       Date:  1977-02       Impact factor: 10.793

  7 in total
  4 in total

Review 1.  Therapeutic aerosols 2--Drugs available by the inhaled route.

Authors:  S W Clarke; S P Newman
Journal:  Thorax       Date:  1984-01       Impact factor: 9.139

2.  Dose response of ipratropium assessed by two methods.

Authors:  C J Allen; A H Campbell
Journal:  Thorax       Date:  1980-02       Impact factor: 9.139

Review 3.  Anticholinergic agents for chronic asthma in adults.

Authors:  M Westby; M Benson; P Gibson
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 4.  Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis.

Authors:  G E Pakes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.